Page last updated: 2024-10-26

diclofenac and Carcinoma, Transitional Cell

diclofenac has been researched along with Carcinoma, Transitional Cell in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwartzenberg, JM1
Smith, DD1
Lindsley, HB1

Other Studies

1 other study available for diclofenac and Carcinoma, Transitional Cell

ArticleYear
Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy.
    The Journal of rheumatology, 1999, Volume: 26, Issue:4

    Topics: Arthritis, Reactive; BCG Vaccine; Butanones; Carcinoma, Transitional Cell; Cytokines; Diagnosis, Dif

1999